Noemi Aiezza

Use of the FebriDx point-of-care test for the exclusion of SARS-CoV-2 diagnosis in a population with acute respiratory infection during the second (COVID-19) wave in Italy

G. Rossolini, A. Bartoloni, A. Pignone, 2021, International Journal of Infectious Diseases.

Resistome and virulome accretion in an NDM-1-producing ST147 sublineage of Klebsiella pneumoniae associated with an outbreak in Tuscany, Italy: a genotypic and phenotypic characterisation.

M. T. Mechi, V. di Pilato, G. Rossolini, 2022, The Lancet. Microbe.

Rapid screening for SARS-CoV-2 VOC-Alpha (202012/01, B.1.1.7) using the Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay

G. Rossolini, S. Pollini, A. Antonelli, 2021, International Journal of Infectious Diseases.

SARS-CoV-2 Spike-Specific CD4+ T Cell Response Is Conserved Against Variants of Concern, Including Omicron

L. Cosmi, F. Annunziato, G. Rossolini, 2022, Frontiers in Immunology.

Activity of fosfomycin/colistin combinations against planktonic and biofilm Gram-negative pathogens.

G. Rossolini, T. di Maggio, L. Pallecchi, 2022, The Journal of antimicrobial chemotherapy.

An allelic variant of the PmrB sensor kinase responsible for colistin resistance in an Escherichia coli strain of clinical origin

C. Galeotti, V. di Pilato, G. Rossolini, 2017, Scientific Reports.

Clinical Features and Outcomes of Bloodstream Infections Caused by New Delhi Metallo-β-Lactamase–Producing Enterobacterales During a Regional Outbreak

M. T. Mechi, V. di Pilato, G. Rossolini, 2020, Open forum infectious diseases.

KPC-53, a KPC-3 Variant of Clinical Origin Associated with Reduced Susceptibility to Ceftazidime-Avibactam

V. di Pilato, G. Rossolini, F. Luzzaro, 2020, Antimicrobial Agents and Chemotherapy.